Laura Lawrence

1.8k total citations
53 papers, 1.2k citations indexed

About

Laura Lawrence is a scholar working on Pharmacology, Infectious Diseases and Molecular Medicine. According to data from OpenAlex, Laura Lawrence has authored 53 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Pharmacology, 26 papers in Infectious Diseases and 17 papers in Molecular Medicine. Recurrent topics in Laura Lawrence's work include Antibiotics Pharmacokinetics and Efficacy (27 papers), Antimicrobial Resistance in Staphylococcus (24 papers) and Antibiotic Resistance in Bacteria (17 papers). Laura Lawrence is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (27 papers), Antimicrobial Resistance in Staphylococcus (24 papers) and Antibiotic Resistance in Bacteria (17 papers). Laura Lawrence collaborates with scholars based in United States, Romania and United Kingdom. Laura Lawrence's co-authors include Sue Cammarata, John F. Barrett, Randall Hoover, Susan K. Paulson, Eugene Sun, Miri Seiberg, Purvi Mehra, Kurt S. Stenn, Erin M. Duffy and Stanley J. Korsmeyer and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Investigative Dermatology and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Laura Lawrence

51 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Lawrence United States 22 541 513 378 277 271 53 1.2k
Caroline Perry United States 19 343 0.6× 334 0.7× 153 0.4× 272 1.0× 657 2.4× 48 1.8k
E Y Ng United States 11 292 0.5× 449 0.9× 607 1.6× 178 0.6× 569 2.1× 12 1.2k
D. M. Ryan United Kingdom 16 186 0.3× 588 1.1× 321 0.8× 369 1.3× 184 0.7× 35 1.1k
Patty Fan‐Havard United States 18 438 0.8× 130 0.3× 188 0.5× 406 1.5× 182 0.7× 33 1.1k
J. Scott Overcash United States 11 373 0.7× 174 0.3× 175 0.5× 194 0.7× 107 0.4× 25 722
Pierrette Gourde Canada 19 198 0.4× 217 0.4× 105 0.3× 246 0.9× 215 0.8× 40 1.0k
G. Arcieri Germany 11 108 0.2× 603 1.2× 212 0.6× 221 0.8× 149 0.5× 17 943
S A Lerner United States 20 402 0.7× 359 0.7× 526 1.4× 293 1.1× 360 1.3× 34 1.3k
Kim Riddell United States 11 65 0.1× 109 0.2× 563 1.5× 247 0.9× 261 1.0× 12 990
Meena Sachdeva United States 16 377 0.7× 216 0.4× 197 0.5× 217 0.8× 259 1.0× 22 858

Countries citing papers authored by Laura Lawrence

Since Specialization
Citations

This map shows the geographic impact of Laura Lawrence's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Lawrence with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Lawrence more than expected).

Fields of papers citing papers by Laura Lawrence

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Lawrence. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Lawrence. The network helps show where Laura Lawrence may publish in the future.

Co-authorship network of co-authors of Laura Lawrence

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Lawrence. A scholar is included among the top collaborators of Laura Lawrence based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Lawrence. Laura Lawrence is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Salata, Robert A., Rodolfo Álvarez-Sala, Juan Pablo Horcajada, et al.. (2019). 2232. A Global Phase 3 Study of Delafloxacin (DLX) Compared with Moxifloxacin (MOX) in Patients with Community-acquired Bacterial Pneumonia (CABP). Open Forum Infectious Diseases. 6(Supplement_2). S762–S762. 1 indexed citations
3.
Hoover, Randall, Harry Alcorn, Laura Lawrence, et al.. (2018). Clinical Pharmacokinetics of Sulfobutylether‐β‐Cyclodextrin in Patients With Varying Degrees of Renal Impairment. The Journal of Clinical Pharmacology. 58(6). 814–822. 27 indexed citations
4.
Hoover, Randall, et al.. (2018). Pharmacokinetics of Intravenous Delafloxacin in Patients With End‐Stage Renal Disease. The Journal of Clinical Pharmacology. 58(7). 913–919. 14 indexed citations
5.
Dawe, Robert, J. Ferguson, Sally H. Ibbotson, et al.. (2018). Lack of phototoxicity potential with delafloxacin in healthy male and female subjects: comparison to lomefloxacin. Photochemical & Photobiological Sciences. 17(6). 773–780. 21 indexed citations
6.
Hoover, Randall, et al.. (2017). Delafloxacin Pharmacokinetics in Subjects With Varying Degrees of Renal Function. The Journal of Clinical Pharmacology. 58(4). 514–521. 28 indexed citations
7.
Paulson, Susan K., et al.. (2017). The Pharmacokinetics of the CYP3A Substrate Midazolam After Steady-state Dosing of Delafloxacin. Clinical Therapeutics. 39(6). 1182–1190. 24 indexed citations
8.
Lawrence, Laura. (2016). A Global Phase 3 Study of Delafloxacin (DLX) Compared to Vancomycin/Aztreonam (VAN/AZ) in Patients with Acute Bacterial Skin and Skin Structure Infections (ABSSSI). 5 indexed citations
9.
Hoover, Randall, Thomas L. Hunt, Susan K. Paulson, et al.. (2015). Single and Multiple Ascending-dose Studies of Oral Delafloxacin: Effects of Food, Sex, and Age. Clinical Therapeutics. 38(1). 39–52. 44 indexed citations
10.
Hoover, Randall, Thomas L. Hunt, Susan K. Paulson, et al.. (2015). Safety, Tolerability, and Pharmacokinetic Properties of Intravenous Delafloxacin After Single and Multiple Doses in Healthy Volunteers. Clinical Therapeutics. 38(1). 53–65. 45 indexed citations
11.
12.
O’Riordan, William, et al.. (2014). A randomized phase 2 study comparing two doses of delafloxacin with tigecycline in adults with complicated skin and skin-structure infections. International Journal of Infectious Diseases. 30. 67–73. 86 indexed citations
13.
Skripkin, Eugene, Timothy McConnell, Joseph A. DeVito, et al.. (2008). Rχ-01, a New Family of Oxazolidinones That Overcome Ribosome-Based Linezolid Resistance. Antimicrobial Agents and Chemotherapy. 52(10). 3550–3557. 61 indexed citations
14.
Mazzucco, Charles E., Laura Lawrence, Hung‐Yao Ho, et al.. (2002). Comparison of the Bactericidal Activities and Post-Antibiotic Effects of the Des-F(6)-Quinolone BMS-284756, Levofloxacin, and Ciprofloxacin Against Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus. European Journal of Clinical Microbiology & Infectious Diseases. 21(1). 27–34. 4 indexed citations
15.
Lawrence, Laura. (2001). The inhibition and selectivity of bacterial topoisomerases by BMS-284756 and its analogues. Journal of Antimicrobial Chemotherapy. 48(2). 195–201. 20 indexed citations
16.
Wu, Ping, Laura Lawrence, Kenneth DenBleyker, & John F. Barrett. (2001). Mechanism of Action of the Des-F(6) Quinolone BMS-284756 Measured by Supercoiling Inhibition and Cleavable Complex Assays. Antimicrobial Agents and Chemotherapy. 45(12). 3660–3662. 5 indexed citations
17.
Discotto, Linda, Michael J. Pucci, Laura Lawrence, & John F. Barrett. (1998). 38th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), September 24-27, 1998, San Diego, CA, USA. Expert Opinion on Investigational Drugs. 7(12). 2061–2077. 2 indexed citations
18.
Frosco, MaryBeth, Michael J. Pucci, Laura Lawrence, et al.. (1997). The 97th Annual Meeting of the American Society for Microbiology. Expert Opinion on Investigational Drugs. 6(7). 899–813. 9 indexed citations
19.
Stevenson, Roger E., J. Fernando Arena, Melanie May, et al.. (1997). Arch fingerprints, hypotonia, and areflexia associated with X linked mental retardation.. Journal of Medical Genetics. 34(6). 465–469. 18 indexed citations
20.
Bialer, Martin G., Laura Lawrence, Roger E. Stevenson, et al.. (1992). Allan‐herndon‐dudley syndrome: Clinical and linkage studies on a second family. American Journal of Medical Genetics. 43(1-2). 491–497. 34 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Caroline Perry Breakdown of academic impact, for papers by E Y Ng Breakdown of academic impact, for papers by D. M. Ryan Breakdown of academic impact, for papers by Patty Fan‐Havard Breakdown of academic impact, for papers by J. Scott Overcash Breakdown of academic impact, for papers by Pierrette Gourde Breakdown of academic impact, for papers by G. Arcieri Breakdown of academic impact, for papers by S A Lerner Breakdown of academic impact, for papers by Kim Riddell Breakdown of academic impact, for papers by Meena Sachdeva
Rankless by CCL
2026